---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-277914"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T06:34:49.562894+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Elevance Health issues $1.8B of notes in three tranches at 5.35%-6.10%

## Summary
- $400M 5.350% notes due 2025, $650M 5.500% notes due 2032, $750M 6.100% notes due 2052.
- Net proceeds of approx. $1.7802B after underwriting discounts and offering expenses.
- Intends to use proceeds for working capital, acquisitions, debt repayment, and share repurchases.
- Underwriters: BofA Securities and Deutsche Bank Securities as representatives.
- Notes registered under Form S-3; interest semi-annual beginning April 15, 2023.

## SEC filing metadata
- accession: 0001193125-22-277914
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312522277914/0001193125-22-277914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312522277914/d416104d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-277914
- JSON: https://secwatch.observer/filing/0001193125-22-277914.json
- Plain text: https://secwatch.observer/filing/0001193125-22-277914.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.